Eiji Hishinuma
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 17
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 8
-
- Drug Transport and Resistance Mechanisms 7
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 4
-
- Metabolomics and Mass Spectrometry Studies 10
- Biochemical and Molecular Research 6
-
- Diet and metabolism studies 4
- Co-authors
- Daisuke SaigusaMasahiro HiratsukaMasayuki YamamotoS. KoshibaNoriyasu HirasawaSakae SaitoKengo KinoshitaShu Tadaka
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Eiji Hishinuma
41 papers receiving 581 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 139
- Clinical Biochemistry 49
- Cancer Research 83
- Biochemistry 35
- Oncology 131
Countries citing papers authored by Eiji Hishinuma
This map shows the geographic impact of Eiji Hishinuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Hishinuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Hishinuma more than expected).
Fields of papers citing papers by Eiji Hishinuma
This network shows the impact of papers produced by Eiji Hishinuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Hishinuma. The network helps show where Eiji Hishinuma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eiji Hishinuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 9 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 17 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 0 | |
| 18 | 2018 | 31 | |
| 19 | 2018 | 6 | |
| 20 | 2017 | 11 |
About Eiji Hishinuma
Eiji Hishinuma is a scholar working on Pharmacology, Clinical Biochemistry and Transplantation, having authored 45 papers that have together received 583 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Metabolism and Genetic Disorders (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Biochemical and Molecular Research (6 papers), Diet and metabolism studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Pharmacology (139 citations), Clinical Biochemistry (49 citations) and Cancer Research (83 citations). Eiji Hishinuma has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Daisuke Saigusa, Masahiro Hiratsuka, Masayuki Yamamoto, S. Koshiba, Noriyasu Hirasawa, Sakae Saito, Kengo Kinoshita, Shu Tadaka, Hong Liu and Masamitsu Maekawa.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.